StockData
Enanta Pharmaceuticals Inc logo

Enanta Pharmaceuticals Inc (ENTA) stock

ENTANasdaqPharmaceutical PreparationsFiscal year ends September 30
Số liệu tài chính tới Q4 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-K on Nov 18, 2026Score 2/302% above fair value
$8.69−1.98 (-18.56%)

Close on Nov 17, 2026Market cap $253.10MP/E –Yield –

Enanta Pharmaceuticals enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Enanta Pharmaceuticals's enterprise value was $148.29M on Nov 11, 2026, against $113.12M a year earlier. Over the last 5 years it ranged from -$196.66M to $1.27B, with a median of $148.29M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$148.29M-0.1%
2025Dec 31, 2025$148.41M–
2024Dec 31, 2024-$125.21M–
2023Dec 29, 2023-$171.74M-123.9%
2022Dec 30, 2022$717.97M-43.4%
2021Dec 31, 2021$1.27B+176.8%
2020Dec 31, 2020$458.59M-48.0%
2019Dec 31, 2019$882.02M-17.2%
2018Dec 31, 2018$1.07B+18.6%
2017Dec 29, 2017$898.29M+44.6%
2016Dec 30, 2016$621.13M+31.4%
2015Dec 31, 2015$472.82M-44.7%
2014Dec 31, 2014$854.77M+120.5%
2013Dec 31, 2013$387.64M–

More Enanta Pharmaceuticals figures

See a number that looks wrong?